Colorectal Cancer Screening Validation Study

Status unconfirmed

Conditions studied: Colorectal Cancer Screening

In brief

The purpose of this study is to evaluate the gene expression patterns from colorectal mucosal cells collected through the use of a standard anoscope and cytology brush. Patients will include those scheduled for routine colonoscopy procedures and those with confirmed colorectal cancer.

Key facts

Study ID

NCT00720993

Run by

IntelliGeneScan, Inc.

People needed

165

Starts

2008-08-01

Expected to finish

2009-05-01

Last updated by the study team

2009-04-23

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• willing to provide informed consent
• greater than or equal to 50 years of age
• patient is scheduled for routine colonoscopy procedure or colorectal cancer surgery
• subject is willing to provide colorectal mucosal sample for gene expression testing

You may not qualify if…

• recent radiation or treatment for gynecologic, prostate or rectal cancer
• recent surgery for anal rectal disease
• polys, family or self history of cancer (control group only)
• GI disease
• any mucosal disease or systemic condition that may confound the scientific interpretation of the gene expression results

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.